Multiple myeloma is characterized by clonal proliferation of plasma cells that accumulate preferentially in the bone marrow (BM). The tumor microenvironment is one of the leading factors that promote tumor progression. Neutrophils and monocytes are a major part of the BM tumor microenvironment, but the mechanism of their contribution to multiple myeloma progression remains unclear. Here, we describe a novel mechanism by which S100A8/S100A9 proteins produced by BM neutrophils and monocytes promote the expansion of megakaryocytes supporting multiple myeloma progression. S100A8/S100A9 alone was not sufficient to drive megakaryopoiesis but markedly enhanced the effect of thrombopoietin, an effect that was mediated by Toll-like receptor 4 and activation of the STAT5 transcription factor. Targeting S100A9 with tasquinimod as a single agent and in combination with lenalidomide and with proteasome inhibitors has potent antimyeloma effect that is at least partly independent of the adaptive immune system. This newly identified axis of signaling involving myeloid cells and megakaryocytes may provide a new avenue for therapeutic targeting in multiple myeloma.
Pubmed ID: 36923707 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Mus musculus with name C57BL/6Smoc-Mokem1Smoc from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name FVB/NJ from IMSR.
View all literature mentionsNSG-HLA-A2/HHD mutant mice are immunodeficient and express human HLA class 1 heavy and light chains. This strain may be useful as a human hematopoietic engraftment host that supports the maturation of human T cells with transplantation http://jaxmice.jax.org/strain/014570.html.
View all literature mentionsThis unknown targets epitope mapping at the C-terminus of PECAM-1 of human origin
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets Phospho-Stat5 (Tyr694) (D47E7) XP Rabbit mAb
View all literature mentionsThis monoclonal targets His-Tag
View all literature mentionsThis monoclonal targets CD34
View all literature mentionsThis monoclonal targets CD147
View all literature mentions
Mus musculus with name NOD.Cg-Prkdcscid Il2rg
Mus musculus with name CB17/Icr-Prkdcscid/IcrCr from IMSR.
View all literature mentionsMus musculus with name B6(Cg)-Tlr4tm1.2Karp/J from IMSR.
View all literature mentionsCell line NCI-H929 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line MM1.S is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line 5TGM1 is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentions